Irinotecan Qilu Pharma Spain 20 mg/ml inf. opl. (conc.) i.v. flac. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.

qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan

Irinotecan Qilu Pharma Spain 20 mg/ml inf. opl. (conc.) i.v. flac. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.

qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan

Irinotecan Qilu Pharma Spain  20 mg/ml inf. opl. (conc.) i.v. flac. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.

qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan

Irinotecan Qilu Pharma Spain  20 mg/ml inf. opl. (conc.) i.v. flac. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan qilu pharma spain 20 mg/ml inf. opl. (conc.) i.v. flac.

qilu pharma spain s.l. - irinotecanhydrochloridetrihydraat 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentraat voor oplossing voor infusie - 20 mg/ml - irinotecanhydrochloridetrihydraat 20 mg/ml - irinotecan

Tramvetol 50 mg tabletten voor honden Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

tramvetol 50 mg tabletten voor honden

virbac sa - tramadolhydrochloride; tramadol - tablet - tramadolhydrochloride 50 mg/stuk; tramadol 43,9 mg/stuk, - tramadol - honden

Spikevax (previously COVID-19 Vaccine Moderna) Europese Unie - Nederlands - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccins - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Librela Europese Unie - Nederlands - EMA (European Medicines Agency)

librela

zoetis belgium - bedinvetmab - pijnstillers - honden - for the alleviation of pain associated with osteoarthritis in dogs.

Prucalopride Koanaa Healthcare 1 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prucalopride koanaa healthcare 1 mg filmomh. tabl.

koanaa healthcare spain s.l. - prucalopridesuccinaat 1,321 mg - eq. prucalopride 1 mg - filmomhulde tablet - 1 mg - prucalopridesuccinaat 1.321 mg - prucalopride

Prucalopride Koanaa Healthcare 2 mg filmomh. tabl. België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prucalopride koanaa healthcare 2 mg filmomh. tabl.

koanaa healthcare spain s.l. - prucalopridesuccinaat 2,642 mg - eq. prucalopride 2 mg - filmomhulde tablet - 2 mg - prucalopridesuccinaat 2.642 mg - prucalopride

Nevanac Europese Unie - Nederlands - EMA (European Medicines Agency)

nevanac

novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - ophthalmologica - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.